Wirkstoffe & Arzneimittelsicherheit

Nebenwirkungen · Exforge HCT

Exforge HCT 5 mg/160 mg/12.5 mg film-coated tablets Exforge HCT 10 mg/160 mg/12.5 mg film-coated tablets Exforge HCT 5 mg/160 mg/25 mg film-coated tablets Exforge HCT 10 mg/160 mg/25 mg film-coated tablets Exforge HCT 10 mg/320 mg/25 mg film-coated tablets · Abschnitt 4.8 · PDF-Seite 14

HOS-121637 · Präparat HOS-095405

MedDRA Adverse reactions Frequency System Organ Exforge Amlodipine Valsartan HCT Class HCT Neoplasms Non-melanoma skin cancer -- -- -- Not benign, (Basal cell carcinoma and known malignant and Squamous cell carcinoma) unspecified (incl cysts and polyps) Blood and Agranulocytosis, bone -- -- -- Very rare lymphatic system marrow failure disorders Haemoglobin and -- -- Not known -- haematocrit decreased Haemolytic anaemia -- -- -- Very rare Leukopenia -- Very rare -- Very rare Neutropenia -- -- Not known -- Thrombocytopenia, -- Very rare Not known Rare sometimes with purpura Aplastic anaemia -- -- -- Not known Immune system Hypersensitivity -- Very rare Not known Very rare disorders

Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.